A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

Patrick Sin-Chan, Iqra Mumal, Tannu Suwal, Ben Ho, Xiaolian Fan, Irtisha Singh, Yuchen Du, Mei Lu, Neilket Patel, Jonathon Torchia, Dean Popovski, Maryam Fouladi, Paul Guilhamon, Jordan R. Hansford, Sarah Leary, Lindsey M. Hoffman, Jean M. Mulcahy Levy, Alvaro Lassaletta, Palma Solano-Paez, Eloy RivasAlyssa Reddy, G. Yancey Gillespie, Nalin Gupta, Timothy E. Van Meter, Hideo Nakamura, Tai Tong Wong, Young Shin Ra, Seung Ki Kim, Luca Massimi, Richard G. Grundy, Jason Fangusaro, Donna Johnston, Jennifer Chan, Lucie Lafay-Cousin, Eugene I. Hwang, Yin Wang, Daniel Catchpoole, Jean Michaud, Benjamin Ellezam, Ramya Ramanujachar, Holly Lindsay, Michael D. Taylor, Cynthia E. Hawkins, Eric Bouffet, Nada Jabado, Sheila K. Singh, Claudia L. Kleinman, Dalia Barsyte-Lovejoy, Xiao Nan Li, Peter B. Dirks, Charles Y. Lin, Stephen C. Mack, Jeremy N. Rich, Annie Huang*

*Corresponding author for this work

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Embryonal tumors with multilayered rosettes (ETMRs) are highly lethal infant brain cancers with characteristic amplification of Chr19q13.41 miRNA cluster (C19MC) and enrichment of pluripotency factor LIN28A. Here we investigated C19MC oncogenic mechanisms and discovered a C19MC-LIN28A-MYCN circuit fueled by multiple complex regulatory loops including an MYCN core transcriptional network and super-enhancers resulting from long-range MYCN DNA interactions and C19MC gene fusions. Our data show that this powerful oncogenic circuit, which entraps an early neural lineage network, is potently abrogated by bromodomain inhibitor JQ1, leading to ETMR cell death. Sin-Chan et al. uncover a C19MC-LIN28A-MYCN super-enhancer-dependent oncogenic circuit in embryonal tumors with multilayered rosettes (ETMRs). The circuit entraps an early neural lineage network to sustain embryonic epigenetic programming and is vulnerable to bromodomain inhibition, which promotes ETMR cell death.

Original languageEnglish (US)
Pages (from-to)51-67.e7
JournalCancer Cell
Volume36
Issue number1
DOIs
StatePublished - Jul 8 2019

Keywords

  • C19MC
  • ETMR
  • LIN28A
  • MYCN
  • brain tumor
  • cell-cycle
  • epigenetics
  • microRNA
  • super-enhancer
  • therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Fingerprint Dive into the research topics of 'A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor'. Together they form a unique fingerprint.

Cite this